Browsing: Conditions

NEW YORK, July 28, 2026 /PRNewswire/ — Mirae, an AI-driven continuous care platform for autoimmune disease and other complex chronic conditions, today announced $5.4 million in funding led by Oxford Science Enterprises. Mirae captures what patients experience between visits and converts it into acontinuous, structured view of disease that clinicians can act on at the point…

Glucagon-like peptide-1 (GLP-1) is a hormone that helps regulate blood glucose levels, slow digestion, and promote a sense of fullness. GLP-1 medications mimic GLP-1 in the body to reduce blood glucose and support weight loss

In an interim analysis of the phase III ELEVATE trial reported in The New England Journal of Medicine, Yue et al found that patients with completely resected ALK-positive non–small cell lung cancer (NSCLC) who received adjuvant ensartinib experienced significantly longer disease-free survival than those receiving placebo. The investigators conducted the study to determine whether the…